Prof. Paul Gugliuzza shares his take on the legal dispute over Moderna’s patent for an mRNA molecule and what it illustrates about the nature of innovation today. Read More

Dean Rachel Rebouche says a 5th Circuit ruling that HHS cannot compel hospitals to provide gender-affirming care if it contradicts their religious beliefs may have implications for abortion access as well. Read More

Dean Rachel Rebouche contributes to this New Yorker piece on Justice Alito. Read More

Dean Rachel Rebouche and co-authors David S. Cohen and Greer Donley offer a roadmap for the abortion rights movement in their Stanford Law Review essay, Rethinking Strategy After Dobbs. Read More

Malvern-based opioid manufacturer Endo paid out millions in two rounds of bonuses to corporate leaders in the months before filing for bankruptcy. Prof. Jonathan Lipson says people should ask why the company is rewarding those who oversaw its demise. Read More

A bipartisan bill to codify Roe and Casey is getting a tepid reaction from abortion rights groups who say it is not explicit enough to overcome Chief Justice Roberts’ willingness to gut the viability standard. Dean Rachel Rebouche sees it differently. Read More

GenBioPro, which makes one of the drugs used in medication abortion, has withdrawn its suit challenging Mississippi’s abortion ban. Dean Rachel Rebouche says that Dobbs has changed the nature of the legal questions at issue. Read More

Prof. Lauren Ouziel joins former NSA lawyer Glenn Gerstell and Guardian congressional reporter Hugo Lowell in a conversation about former President Trump’s growing legal trouble on Radio Times. Read More

Prof. Jonathan Lipson says that opioid manufacturer Endo’s bankruptcy litigation doesn’t seem to have any “highly visible bad guys,” a marked difference from cases like Purdue Pharma. Read More

Prof. Gilat Bachar’s work exploring the impact of mandatory NDAs in workplace harassment cases was reviewed in JOTWELL. Check it out! Read More